论文部分内容阅读
目的观察肾消汤联合雷公藤多苷片治疗糖尿病肾病IV期气阴两虚兼瘀浊证的临床有效性。方法54例糖尿病肾病患者(气阴两虚兼瘀浊证),在给予常规治疗基础上随机分为对照组26例和治疗组28例,对照组口服雷公藤多苷片,20mg,3次/日,治疗组在口服雷公藤的基础上加服肾消汤,1剂/日。两组均观察12周。观察患者治疗前后临床症状变化,检测24 h-TP、Scr、Bun、Alb、ALT、WBC、CRP指标变化。结果 (1)治疗组中医症状总积分治疗后较治疗前显著改善(P<0.01),对照组无显著差异(P>0.05)。(2)两组治疗后24 h-TP、CRP均较治疗前改善,且治疗组经优于对照组(P<0.05),两组患者肾功在治疗前、后比较差异无统计学意义(P>0.05)。结论肾消汤联合雷公藤多苷片可明显改善糖尿病肾病IV期气阴两虚兼瘀浊证各项指标及临床症状,并能减少不良反应,疗效确切。
Objective To observe the clinical efficacy of Shenxiao Decoction combined with Tripterygium Wilfordii glycosides tablet in the treatment of stage IV Qi and Yin Deficiency Syndrome and Blood Stasis Syndromes in patients with diabetic nephropathy. Methods Fifty - four patients with diabetic nephropathy (Qi - Yin Deficiency and Blood Stasis Syndrome) were randomly divided into control group (n = 26) and treatment group (n = 28) Day, the treatment group on the basis of oral Tripterygium plus serving kidney decoction, 1 / day. Both groups were observed for 12 weeks. The changes of clinical symptoms before and after treatment were observed. The changes of 24 h-TP, Scr, Bun, Alb, ALT, WBC and CRP were detected. Results (1) The total score of TCM symptoms in treatment group was significantly improved after treatment (P <0.01), but there was no significant difference in control group (P> 0.05). (2) The 24 h-TP and CRP in both groups improved compared with that before treatment, and the treatment group was superior to the control group (P <0.05). There was no significant difference in renal function between the two groups before and after treatment P> 0.05). Conclusion Decoction combined with Tripterygium Wilfordii glycosides tablet can significantly improve the diabetic nephropathy IV Qi and Yin and blood stasis Syndrome various indicators and clinical symptoms, and can reduce the adverse reactions, the exact effect.